Accenture trades at historically low valuations, with a forward P/E of 9.3 and a forward P/FCF below 8, despite its strong ...

Welcome to your monthly legal insights on the trends impacting the Retail, Hospitality, and Food & Beverage Industries.

TRU leads risk-adjusted returns via fraud/identity and emerging markets. Click here to read my most recent analysis.

BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response ('DDR”) inhibitors, a category of drugs that work by blocking cancer ...